Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.
about
Atypical hemolytic uremic syndromeHemolytic uremic syndrome: new developments in pathogenesis and treatmentClinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in KoreaA systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)Haemolytic uraemic syndrome.Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristicsNeonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria.Multifaceted hemolytic uremic syndrome in pediatrics.cblE-Type Homocystinuria Presenting with Features of Haemolytic-Uremic Syndrome in the Newborn Period.[Pathophysiology of atypical hemolytic uremic syndrome. Ten years of progress, from laboratory to patient].Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic SyndromeAn international consensus approach to the management of atypical hemolytic uremic syndrome in children.Clinical characteristics of hemolytic uremic syndrome secondary to cobalamin C disorder in Chinese children.Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte.Combined methylmalonic acidemia and homocystinuria, cblC type. II. Complications, pathophysiology, and outcomes.Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.Cobalamin C defect: natural history, pathophysiology, and treatment.Renal dysfunction in methylmalonic acidurias: review for the pediatric nephrologist.Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity.Thrombotic microangiopathies: a general approach to diagnosis and management.Endothelial cells: source, barrier, and target of defensive mediators.Inborn Errors of Metabolism and Epilepsy: Current Understanding, Diagnosis, and Treatment Approaches.Diagnosis of cobalamin C deficiency with renal abnormality from onset in a Chinese child by next generation sequencing: A case report.CD46-associated atypical hemolytic uremic syndrome with uncommon course caused by cblC deficiency.Atypical adult-onset methylmalonic acidemia and homocystinuria presenting as hemolytic uremic syndrome.A child presenting with severe hypertension and circulatory failure-a diagnostic conundrum: Answers.Reversible pulmonary arterial hypertension in cobalamin-dependent cobalamin C disease due to a novel mutation in the MMACHC gene.Clinical presentation and outcome in a series of 88 patients with the cblC defect.Cobalamin C defect-hemolytic uremic syndrome caused by new mutation in MMACHC.Management of hemolytic uremic syndromeHemolytic uremic syndrome
P2860
Q21202864-A0CCC926-F532-4F6F-BE96-DD94F788AF3DQ24613517-F83D239C-BC17-41FB-B7F8-8E28F1807DB4Q26739894-F80221B5-BADE-4F23-A162-00BBACD68B0BQ28661698-C03CA07B-1EFE-4095-AA74-E3EB2D15186AQ30244707-9E6D7F8C-1F6F-41BC-B4C2-C49607C2ED8EQ33400211-C19262EF-91C1-4DB0-AA25-DB01AA8DB99BQ33400399-EB0E4720-D7CA-4B77-A0A5-3E0057829035Q33405452-9D51BA07-807A-479C-AC79-D18D35EA8713Q33406017-B420C585-1DFD-4B4D-8D85-5B5214AC4A98Q33413660-E6E5392F-9B09-4DCA-AD31-37B11AFB5312Q33421800-E81B6BF5-CDB7-47C2-989A-F275B4800600Q33421861-C3A2608E-4EC9-47AC-A890-CBEAA06EFCF7Q33425028-5E610DE1-2C00-4897-ABFB-F8B1E2366E60Q33436972-5E4D1BEB-3E3F-49C8-8F63-27E520A2BBD5Q34038698-E2F18523-C53A-4580-9322-49D24F285468Q36485435-A5264B4D-B4F0-4680-8894-4B1A09A225C4Q37322141-71D2ECF3-4891-458F-84C1-0F81D60D2960Q37547491-CE4B0631-2040-4D66-A355-F3E20B307843Q37772799-AA75F43E-ABF4-4D47-BACD-6D6D4064B0D0Q38027777-3A5D754F-1817-4D71-ADCB-0E3CFE409DFEQ38862309-464BA3B3-D87E-4114-A1A4-36B5E15CCAEBQ38984066-387F256A-C7C7-4318-AB4F-8BBE0DAE639EQ38991026-008ABC9D-AE33-4497-A51B-D1D71178FB8AQ39411002-1E38C7E3-AA82-4B22-A8EC-58800527AA66Q42376293-AAB36D64-A6F8-41B9-85A2-9FEBCE740C18Q42400206-39D67FCB-78F9-4677-A885-3950F710D437Q48320572-CE39BB34-617D-409F-98DA-0E0169E43B66Q49118448-CAF27567-E707-4546-BB95-145330FBA702Q50660737-27E8F75D-3CF8-4765-8890-BCF59615F190Q50682539-B86C9DF2-9C55-47C0-9876-A3CD7BEE9D72Q51692263-1B1532DB-0F95-47D3-87E0-3198C2865DB2Q57161996-6765217E-7A78-460B-834C-2DE2178A452EQ57701679-CAFDA856-C22C-49F8-B9FF-D9D13495C400
P2860
Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.
@ast
Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.
@en
type
label
Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.
@ast
Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.
@en
prefLabel
Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.
@ast
Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.
@en
P2093
P1433
P1476
Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.
@en
P2093
Ajay P Sharma
Asuri N Prasad
Cheryl R Greenberg
Chitra Prasad
P2888
P304
P356
10.1007/S00467-007-0604-1
P577
2007-09-14T00:00:00Z
P6179
1025707228